Header Logo

Connection

Cheryl Cohen to Aged

Back to Details
This is a "connection" page, showing publications Cheryl Cohen has written about Aged.
Cheryl Cohen
Connection Strength
3,760
Aged
  1. Home-Based Testing as an Approach to Estimate Influenza Vaccine Effectiveness in South Africa, 2021-2022-A Pilot Study. Influenza Other Respir Viruses. 2024 12; 18(12):e70034.
    View in: PubMed
    Score: 0,165
  2. Risk factors for severe respiratory syncytial virus-associated respiratory tract infection in a high HIV prevalence setting, South Africa, 2012 - 2018. BMC Infect Dis. 2024 Oct 09; 24(1):1128.
    View in: PubMed
    Score: 0,164
  3. Estimation of vaccine effectiveness against SARS-CoV-2-associated hospitalization using sentinel surveillance in South Africa. Int J Epidemiol. 2024 Aug 14; 53(5).
    View in: PubMed
    Score: 0,162
  4. The national burden of influenza-like illness and severe respiratory illness overall and associated with nine respiratory viruses in South Africa, 2013-2015. Influenza Other Respir Viruses. 2022 05; 16(3):438-451.
    View in: PubMed
    Score: 0,136
  5. Asymptomatic transmission and high community burden of seasonal influenza in an urban and a rural community in South Africa, 2017-18 (PHIRST): a population cohort study. Lancet Glob Health. 2021 06; 9(6):e863-e874.
    View in: PubMed
    Score: 0,130
  6. A cost-effectiveness analysis of South Africa's seasonal influenza vaccination programme. Vaccine. 2021 01 08; 39(2):412-422.
    View in: PubMed
    Score: 0,125
  7. Influenza economic burden among potential target risk groups for immunization in South Africa, 2013-2015. Vaccine. 2020 10 21; 38(45):7007-7014.
    View in: PubMed
    Score: 0,124
  8. Influenza disease burden among potential target risk groups for immunization in South Africa, 2013-2015. Vaccine. 2020 06 02; 38(27):4288-4297.
    View in: PubMed
    Score: 0,120
  9. Household Transmission of Seasonal Influenza From HIV-Infected and HIV-Uninfected Individuals in South Africa, 2013-2014. J Infect Dis. 2019 04 19; 219(10):1605-1615.
    View in: PubMed
    Score: 0,112
  10. Prioritization of risk groups for influenza vaccination in resource limited settings - A case study from South Africa. Vaccine. 2019 01 03; 37(1):25-33.
    View in: PubMed
    Score: 0,109
  11. The effects of the attributable fraction and the duration of symptoms on burden estimates of influenza-associated respiratory illnesses in a high HIV prevalence setting, South Africa, 2013-2015. Influenza Other Respir Viruses. 2018 05; 12(3):360-373.
    View in: PubMed
    Score: 0,103
  12. In- and Out-of-hospital Mortality Associated with Seasonal and Pandemic Influenza and Respiratory Syncytial Virus in South Africa, 2009-2013. Clin Infect Dis. 2018 01 06; 66(1):95-103.
    View in: PubMed
    Score: 0,102
  13. Attributable Fraction of Influenza Virus Detection to Mild and Severe Respiratory Illnesses in HIV-Infected and HIV-Uninfected Patients, South Africa, 2012-2016. Emerg Infect Dis. 2017 07; 23(7):1124-1132.
    View in: PubMed
    Score: 0,099
  14. Estimating vaccine effectiveness in preventing laboratory-confirmed influenza in outpatient settings in South Africa, 2015. Influenza Other Respir Viruses. 2017 03; 11(2):177-181.
    View in: PubMed
    Score: 0,095
  15. Knowledge, attitudes, and practices about influenza illness and vaccination: a cross-sectional survey in two South African communities. Influenza Other Respir Viruses. 2016 09; 10(5):421-8.
    View in: PubMed
    Score: 0,091
  16. Deaths associated with respiratory syncytial and influenza viruses among persons =5 years of age in HIV-prevalent area, South Africa, 1998-2009(1). Emerg Infect Dis. 2015 Apr; 21(4):600-8.
    View in: PubMed
    Score: 0,085
  17. Mortality amongst patients with influenza-associated severe acute respiratory illness, South Africa, 2009-2013. PLoS One. 2015; 10(3):e0118884.
    View in: PubMed
    Score: 0,084
  18. Epidemiology of severe acute respiratory illness (SARI) among adults and children aged =5 years in a high HIV-prevalence setting, 2009-2012. PLoS One. 2015; 10(2):e0117716.
    View in: PubMed
    Score: 0,084
  19. Influenza virus infection is associated with increased risk of death amongst patients hospitalized with confirmed pulmonary tuberculosis in South Africa, 2010-2011. BMC Infect Dis. 2015 Jan 27; 15:26.
    View in: PubMed
    Score: 0,084
  20. Hospitalizations associated with influenza and respiratory syncytial virus among patients attending a network of private hospitals in South Africa, 2007-2012. BMC Infect Dis. 2014 Dec 16; 14:694.
    View in: PubMed
    Score: 0,083
  21. Epidemiology of influenza virus types and subtypes in South Africa, 2009-2012. Emerg Infect Dis. 2014 Jul; 20(7):1162-9.
    View in: PubMed
    Score: 0,080
  22. Influenza epidemiology and vaccine effectiveness among patients with influenza-like illness, viral watch sentinel sites, South Africa, 2005-2009. PLoS One. 2014; 9(4):e94681.
    View in: PubMed
    Score: 0,079
  23. Severe influenza-associated respiratory infection in high HIV prevalence setting, South Africa, 2009-2011. Emerg Infect Dis. 2013 Nov; 19(11):1766-74.
    View in: PubMed
    Score: 0,077
  24. Influenza-related mortality among adults aged 25-54 years with AIDS in South Africa and the United States of America. Clin Infect Dis. 2012 Oct; 55(7):996-1003.
    View in: PubMed
    Score: 0,070
  25. Elevated influenza-related excess mortality in South African elderly individuals, 1998-2005. Clin Infect Dis. 2010 Dec 15; 51(12):1362-9.
    View in: PubMed
    Score: 0,062
  26. Corynebacterium diphtheriae Infections, South Africa, 2015-2023. Emerg Infect Dis. 2025 Mar; 31(3):417-426.
    View in: PubMed
    Score: 0,042
  27. Cohort profile: the potentially preventable burden of community-acquired pneumonia in South African adults in the era of widespread PCV13 immunisation and antiretroviral therapy roll-out, before and during the COVID-19 pandemic - the multicentre, multimethod PotPrev Study. BMJ Open. 2024 12 20; 14(12):e080553.
    View in: PubMed
    Score: 0,041
  28. Global impact of ten-valent and 13-valent pneumococcal conjugate vaccines on invasive pneumococcal disease in all ages (the PSERENADE project): a global surveillance analysis. Lancet Infect Dis. 2025 Apr; 25(4):457-470.
    View in: PubMed
    Score: 0,041
  29. Long-term effect of pneumococcal conjugate vaccines on invasive pneumococcal disease incidence among people of all ages from national, active, laboratory-based surveillance in South Africa, 2005-19: a cohort observational study. Lancet Glob Health. 2024 Sep; 12(9):e1470-e1484.
    View in: PubMed
    Score: 0,041
  30. Change in Age profile of Respiratory Syncytial Virus disease over the course of annual epidemics: a multi-national study. J Infect. 2024 May; 88(5):106154.
    View in: PubMed
    Score: 0,039
  31. Knowledge, attitudes, practices and intention to get vaccinated against COVID-19: results from a cross-sectional survey in three peri-urban communities in South Africa. Pan Afr Med J. 2023; 45:120.
    View in: PubMed
    Score: 0,038
  32. Optimal age targeting for pneumococcal vaccination in older adults; a modelling study. Nat Commun. 2023 02 16; 14(1):888.
    View in: PubMed
    Score: 0,037
  33. Unmasking Pneumococcal Carriage in a High Human Immunodeficiency Virus (HIV) Prevalence Population in two Community Cohorts in South Africa, 2016-2018: The PHIRST Study. Clin Infect Dis. 2023 02 08; 76(3):e710-e717.
    View in: PubMed
    Score: 0,036
  34. Respiratory syncytial virus prevention within reach: the vaccine and monoclonal antibody landscape. Lancet Infect Dis. 2023 01; 23(1):e2-e21.
    View in: PubMed
    Score: 0,035
  35. COVID-19 vaccine hesitancy in rural South Africa: Deepening understanding to increase uptake and access. J Glob Health. 2022 May 14; 12:05013.
    View in: PubMed
    Score: 0,035
  36. Effectiveness of the Ad26.COV2.S vaccine in health-care workers in South Africa (the Sisonke study): results from a single-arm, open-label, phase 3B, implementation study. Lancet. 2022 03 19; 399(10330):1141-1153.
    View in: PubMed
    Score: 0,034
  37. Difference in mortality among individuals admitted to hospital with COVID-19 during the first and second waves in South Africa: a cohort study. Lancet Glob Health. 2021 09; 9(9):e1216-e1225.
    View in: PubMed
    Score: 0,033
  38. Global burden of influenza-associated lower respiratory tract infections and hospitalizations among adults: A systematic review and meta-analysis. PLoS Med. 2021 03; 18(3):e1003550.
    View in: PubMed
    Score: 0,032
  39. Use of seasonal influenza and pneumococcal polysaccharide vaccines in older adults to reduce COVID-19 mortality. Vaccine. 2020 07 22; 38(34):5398-5401.
    View in: PubMed
    Score: 0,030
  40. Declining Incidence of Invasive Meningococcal Disease in South Africa: 2003-2016. Clin Infect Dis. 2019 07 18; 69(3):495-504.
    View in: PubMed
    Score: 0,028
  41. Healthcare seeking behaviour for common infectious syndromes among people in three administrative regions of Johannesburg, South Africa, 2015: a cross-sectional study. Pan Afr Med J. 2019; 33:159.
    View in: PubMed
    Score: 0,028
  42. The Fraction of Rhinovirus Detections Attributable to Mild and Severe Respiratory Illness in a Setting of High Human Immunodeficiency Virus Prevalence, South Africa, 2013-2015. J Infect Dis. 2019 05 05; 219(11):1697-1704.
    View in: PubMed
    Score: 0,028
  43. Healthcare utilization for common infectious disease syndromes in Soweto and Klerksdorp, South Africa. Pan Afr Med J. 2018; 30:271.
    View in: PubMed
    Score: 0,027
  44. Distribution of influenza virus types by age using case-based global surveillance data from twenty-nine countries, 1999-2014. BMC Infect Dis. 2018 06 08; 18(1):269.
    View in: PubMed
    Score: 0,026
  45. Epidemiology and Molecular Identification and Characterization of Mycoplasma pneumoniae, South Africa, 2012-2015. Emerg Infect Dis. 2018 03; 24(3):506-513.
    View in: PubMed
    Score: 0,026
  46. Estimates of global seasonal influenza-associated respiratory mortality: a modelling study. Lancet. 2018 03 31; 391(10127):1285-1300.
    View in: PubMed
    Score: 0,026
  47. Influenza-associated mortality in South Africa, 2009-2013: The importance of choices related to influenza infection proxies. Influenza Other Respir Viruses. 2018 01; 12(1):54-64.
    View in: PubMed
    Score: 0,025
  48. Respiratory syncytial virus in adults with severe acute respiratory illness in a high HIV prevalence setting. J Infect. 2017 10; 75(4):346-355.
    View in: PubMed
    Score: 0,025
  49. Epidemiology of influenza B/Yamagata and B/Victoria lineages in South Africa, 2005-2014. PLoS One. 2017; 12(5):e0177655.
    View in: PubMed
    Score: 0,025
  50. Effectiveness of seasonal influenza vaccination in community-dwelling elderly people: an individual participant data meta-analysis of test-negative design case-control studies. Lancet Respir Med. 2017 03; 5(3):200-211.
    View in: PubMed
    Score: 0,024
  51. Risk factors associated with hospitalisation for influenza-associated severe acute respiratory illness in South Africa: A case-population study. Vaccine. 2016 11 04; 34(46):5649-5655.
    View in: PubMed
    Score: 0,023
  52. HIV Infection and the Epidemiology of Invasive Pneumococcal Disease (IPD) in South African Adults and Older Children Prior to the Introduction of a Pneumococcal Conjugate Vaccine (PCV). PLoS One. 2016; 11(2):e0149104.
    View in: PubMed
    Score: 0,022
  53. Epidemiology of Serotype 1 Invasive Pneumococcal Disease, South Africa, 2003-2013. Emerg Infect Dis. 2016 Feb; 22(2):261-70.
    View in: PubMed
    Score: 0,022
  54. Assessing the impact of pneumococcal conjugate vaccines on invasive pneumococcal disease using polymerase chain reaction-based surveillance: an experience from South Africa. BMC Infect Dis. 2015 Oct 26; 15:450.
    View in: PubMed
    Score: 0,022
  55. Severe Acute Respiratory Illness Deaths in Sub-Saharan Africa and the Role of Influenza: A Case Series From 8 Countries. J Infect Dis. 2015 Sep 15; 212(6):853-60.
    View in: PubMed
    Score: 0,021
  56. High nasopharyngeal pneumococcal density, increased by viral coinfection, is associated with invasive pneumococcal pneumonia. J Infect Dis. 2014 Nov 15; 210(10):1649-57.
    View in: PubMed
    Score: 0,020
  57. Factors associated with ceftriaxone nonsusceptibility of Streptococcus pneumoniae: analysis of South African national surveillance data, 2003 to 2010. Antimicrob Agents Chemother. 2014 Jun; 58(6):3293-305.
    View in: PubMed
    Score: 0,020
  58. Meningococcal serogroup Y lpxL1 variants from South Africa are associated with clonal complex 23 among young adults. J Infect. 2014 May; 68(5):455-61.
    View in: PubMed
    Score: 0,019
  59. Replacement and positive evolution of subtype A and B respiratory syncytial virus G-protein genotypes from 1997-2012 in South Africa. J Infect Dis. 2013 Dec 15; 208 Suppl 3:S227-37.
    View in: PubMed
    Score: 0,019
  60. HIV and influenza virus infections are associated with increased blood pneumococcal load: a prospective, hospital-based observational study in South Africa, 2009-2011. J Infect Dis. 2014 Jan 01; 209(1):56-65.
    View in: PubMed
    Score: 0,019
  61. Influenza surveillance in 15 countries in Africa, 2006-2010. J Infect Dis. 2012 Dec 15; 206 Suppl 1:S14-21.
    View in: PubMed
    Score: 0,018
  62. Introduction of 2009 pandemic influenza A virus subtype H1N1 into South Africa: clinical presentation, epidemiology, and transmissibility of the first 100 cases. J Infect Dis. 2012 Dec 15; 206 Suppl 1:S148-53.
    View in: PubMed
    Score: 0,018
  63. Twenty-five years of outpatient influenza surveillance in South Africa, 1984-2008. J Infect Dis. 2012 Dec 15; 206 Suppl 1:S153-8.
    View in: PubMed
    Score: 0,018
  64. Respiratory viral coinfections identified by a 10-plex real-time reverse-transcription polymerase chain reaction assay in patients hospitalized with severe acute respiratory illness--South Africa, 2009-2010. J Infect Dis. 2012 Dec 15; 206 Suppl 1:S159-65.
    View in: PubMed
    Score: 0,018
  65. Systemic shigellosis in South Africa. Clin Infect Dis. 2012 May; 54(10):1448-54.
    View in: PubMed
    Score: 0,017
  66. Trimethoprim-sulfamethoxazole prophylaxis and antibiotic nonsusceptibility in invasive pneumococcal disease. Antimicrob Agents Chemother. 2012 Mar; 56(3):1602-5.
    View in: PubMed
    Score: 0,017
  67. Persistent high burden of invasive pneumococcal disease in South African HIV-infected adults in the era of an antiretroviral treatment program. PLoS One. 2011; 6(11):e27929.
    View in: PubMed
    Score: 0,017
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.